The “Correlation” Between Statistics and Eugenics
By Aubrey Clayton,
Los Angeles Review of Books
| 07. 18. 2024
Image "Sir Francis Galton" by Spudgun67 from Wikimedia Commons licensed under CC BY-SA 4.0
IN 2013, A SERIES of ads about the dangers of teen pregnancy appeared on New York City subway trains. Sponsored by the city’s Human Resources Administration, the ads cautioned prospective teen parents that babies were likely—surprise!—to exact a heavy toll on their finances, relationships, and job prospects. The ads were formulated as plaintive messages from the babies themselves. One teary-eyed toddler lamented: “I’m twice as likely not to graduate high school because you had me as a teen.” As then-mayor Michael Bloomberg explained, “This campaign makes very clear to young people that there’s a lot at stake when it comes to deciding to raise a child.” The ad campaign was quite rightly ridiculed, in large part because it offered no support services for teens who were, or might become, pregnant.
From a statistical point of view, though, the most objectionable part of the whole campaign was a single word—“because.”
At the bottom of the poster, a footnote contained this statistic: “Kids of teen moms are...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...